Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Desmoid Tumor × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 644 Glioblastoma 325 Gliosarcoma 314 Brain Neoplasms 231 Central Nervous System Neoplasms 206 Astrocytoma 186 Osteosarcoma 179 Gastrointestinal Stromal Tumors 158 Dendritic Cell Sarcoma, Interdigitating 154 Glioma 150 Lymphoma 143 Burkitt Lymphoma 142 Neoplasms 139 Precursor Cell Lymphoblastic Leukemia-Lymphoma 137 Lymphoma, Non-Hodgkin 137 Oligodendroglioma 136 Neuroblastoma 119 Recurrence 118 Lymphoma, Large B-Cell, Diffuse 118 Lymphoma, Follicular 112 Rhabdomyosarcoma 105 Lymphoma, Mantle-Cell 105 Leukemia, Lymphocytic, Chronic, B-Cell 105 Leukemia 104 Breast Neoplasms 104 Lymphoma, Large-Cell, Immunoblastic 99 Lymphoma, B-Cell, Marginal Zone 99 Hodgkin Disease 97 Bone Neoplasms 96 Sarcoma, Kaposi 92

Interventions

Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00928525 2023-10-05

Basket 1

Italian Sarcoma Group

Phase 2 Completed

Advanced Desmoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡